Comparative Effects of Posture Correction Exercises and Papworth Technique in Asthmatic Forward Head Posture

May 4, 2026 updated by: Riphah International University

Comparative Effects of Posture Correction Exercises and Papworth Technique on Dyspnea, Chest Expansion, and Quality of Life in Asthmatic Patients With Forward Head Posture.

This study aims to evaluating and contrasting the effects of posture correction and papworth technique on dyspnea, chest expansion and quality of life in asthmatic patients with forward head.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Asthma is a chronic inflammatory airway disease characterized by airway hyperresponsiveness, reversible air flow obstruction , and bronchial inflammation, resulting in episodic symptoms such as dyspnea, wheezing, chest tightness and cough. In addition to airway pathology, respiratory mechanics and postural deviations can significantly influence disease severity and functional capacity. Forward head posture is a common postural dysfunction that alters cervical- thoracic alignment, increase upper chest dominance during breathing, reduces rib cage mobility and compromises diaphragmatic efficiency. Correction of forward head posture is expected to improve thoracic expansion, optimize musculoskeletal alignment, and facilitate more efficient breathing mechanics, thereby reducing the work of breathing and improving ventilatory efficiency in asthmatic individuals. The papworth breathing technique is a structured respiratory retraining approach that emphasizes diaphragmatic breathing, nasal breathing, and relaxation strategies to reduce dysfunctional breathing patterns and hyperventilation. it has been shown to improve ventilatory control and may enhance expiratory efficiency, potenitally improving physiological parameters such as positive end expiratory pressure. This study will compare the effects of these two interventions on pulmonary function, asthma control , and postural alignment in asthmatic patients with forward head posture , aiming to determine their relative efficacy in improving respiratory mechanics and functional outcomes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
38

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Sheikh Zaid Hospital Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male and female patients 35 to 50 years
  • No history of recent thoracic or cervical spine surgery
  • Patients diagnosed with mild to moderate asthma
  • Stable asthma condition at the time of recruitment.
  • Non smokers
  • Experiencing mild to moderate dyspnea during daily activities presence of forward head posture
  • FEV/FVC ratio < 0.75 with FEV between 60 to 80 percent of predicted values indicating mild to moderate asthma.

Exclusion Criteria:

  • Patients with inflammatory lesion in cervical region.
  • Patients with neurological impairments and cognitive impairments will be excluded.
  • Patients with tendinopathy
  • History of cervical trauma, cervical spine surgery and vertebral fracture.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Posture correction
posture correction exercises
Other: posture correction exercises
posture correction exercises three sessions per week 30-40 minutes Mckenzie exercises three sets of ten repetitions scapular retraction exercises three sets of ten repetitions thoracic extension exercises pectoral muscle stetching 20-30 seconds upper trapezius and Levator scapulae stretching three times per sessions
Experimental: Papwoth technique
papworth technique
Other: papworth teachnique
papworth three sessions per week approximately 30 minutes diaphragmatic breathing 10 minutes per session sow breathing practice 1-2 minutes breath control and breath holding muscle relaxation techniques

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Universal goniometer
Time Frame: 1st day
Forward head posture was assessed using a universal goniometer by measuring the craniovertebral angle .The CVA is defined as the angle formed between a horizontal line passing through the spinous process of the seventh cervical vertebra(c7) and a line connecting to the tragus of the ear. A smaller CVA reflects increased anterior head displacement and reduced cervical lordosis. A CVA of >50 considered normal , values between 40 to 49 considered mild forward head posture while a CVA <40 represents moderate to severe forward head posture.
1st day

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Borg dyspnea scale
Time Frame: 1st day
The borg dyspnea scale is a subjective tool for assessing the intensity of breathessness in patients, often used in fields like pulmonology, cardiology and sport medicine. it ranges from 0 to 10. 0 very slight and 10 very severe.this scale helps clinicians mointor a patients respiratory symptoms during activities like exercises or rehabilitation and adjust treatment plans accordingly.
1st day
Asthma control questionnaire
Time Frame: 1st day
The asthma control questionnaire is a widely used tool for assessing asthma control in patients. It measures various aspects of asthma, including symptoms, frequency of rescue inhaler use, and lung function over the past week. the ACQ includes questions rated on a 7 point scale, with higher scores indicating proorer asthma control. this questionnaire helps clinicians guage treatment effectiveness, track symptom progression and adjust care strategies to improve patient quality of life.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Qurat ul Ain, MS, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Tian QS, Zhou XH kim T-HJAS the effects of combined cervical and scapular stabilization exercises on muscle tone, pain and cervical range of motion in cervical extension type A controlled experimental study 2025
  • Oakley PA, Moustafa IM, Haas JW, Betz JW, Harrison DEJJoCM two methods of forward head posture assessment radiography vs posture and their clinical comparison 2024
  • Maddah T, Daneshmandi H, Alizade MH, Rahmati MBJBp the investigation of relationship between allergic rhinitis with forward head posture and anxiety in childern 2025
  • Dongare S, Rathi K, Rathi GJPM,Journal P. Inhaled coticosteroids its evolution and step wise phramacological treatment strategies for all levels of asthma 2024
  • Plichta J, Kuna P, Panek MJFIL.biologic drugs in thr treatment of chronic inflammatory pulmonary diseases recent developments and future perspectives 2023
  • 1. padem N, Salton C, editors. classification of asthma.Allergy and Asthma proceedings 2019

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 15, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 17, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 17, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 16, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 7, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • S24C14G36028 nosheen

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings